TGFB1 and neoplasm: Treatment of EMT6 tumor-bearing mice with M7824 and M7824mut significantly reduced plasma levels of TGFβ1 after treatment (Fig. 1E), indicating their ability to bind to murine TGFβ1 in vivo.